These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 1682541)

  • 61. [Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
    Magdzik W
    Przegl Epidemiol; 2004; 58(2):241-51. PubMed ID: 15521103
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease.
    Boslego J; Garcia J; Cruz C; Zollinger W; Brandt B; Ruiz S; Martinez M; Arthur J; Underwood P; Silva W
    Vaccine; 1995 Jun; 13(9):821-9. PubMed ID: 7483804
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase II meningococcal B vesicle vaccine trial in New Zealand infants.
    Jackson C; Lennon DR; Sotutu VT; Yan J; Stewart JM; Reid S; Crengle S; Oster P; Ypma E; Aaberge I; Mulholland K; Martin DR
    Arch Dis Child; 2009 Oct; 94(10):745-51. PubMed ID: 18838420
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Immune response to meningococci].
    Flaegstad T
    Tidsskr Nor Laegeforen; 1989 Jan; 109(1):33-6. PubMed ID: 2492123
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine].
    Golovina LI; Kuvakina VI; Alliluev AP; Basnak'ian IA; Sivko RI
    Klin Lab Diagn; 1995; (1):26-9. PubMed ID: 7757362
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine.
    Masterton RG; Youngs ER; Wardle JC; Croft KF; Jones DM
    J Infect; 1988 Sep; 17(2):177-82. PubMed ID: 3141518
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Meningococcal meningitis.
    Lancet; 1989 Mar; 1(8639):647-8. PubMed ID: 2564462
    [No Abstract]   [Full Text] [Related]  

  • 68. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 69. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
    Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
    N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Right age for Meningococcal vaccine.
    John TJ
    Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680
    [No Abstract]   [Full Text] [Related]  

  • 71. Meningococcal B vaccine. An immunogenic vaccine possibly useful during outbreaks.
    Prescrire Int; 2014 Sep; 23(152):201-4. PubMed ID: 25325113
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
    Fijen CA; Kuijper EJ; Drogari-Apiranthitou M; Van Leeuwen Y; Daha MR; Dankert J
    Clin Exp Immunol; 1998 Dec; 114(3):362-9. PubMed ID: 9844044
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987-2013.
    Husain EH; Barakat M; Al-Saleh M
    J Infect Public Health; 2015; 8(5):441-7. PubMed ID: 25779346
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy.
    Binkin N; Band J
    Lancet; 1982 Aug; 2(8293):315-8. PubMed ID: 6124726
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Effect of 2 vaccination strategies on developments during the epidemic of meningococcal A meningitis in N'Djamena (Chad) in 1988].
    Spiegel A; Greindl Y; Lippeveld T; Decam C; Granga D; Nahor N; Bordonado JL; Sperber G; Yankalbe M; Baudon D
    Bull World Health Organ; 1993; 71(3-4):311-5. PubMed ID: 8324849
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results].
    Levy C; Taha MK; Bingen E; Cohen R;
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S49-54. PubMed ID: 22883366
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
    El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
    Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neisseria meningitidis B vaccines.
    Panatto D; Amicizia D; Lai PL; Gasparini R
    Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vaccines against meningococcal meningitis: current status.
    Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.